Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression 2022-01-13 12:32
Enrollment Completed in Phase II Clinical Study of KN026 Combined with KN046 2022-01-13 10:46
Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference 2022-01-13 08:52
CStone announces phase 2 GEMSTONE-201 trial met primary endpoint of objective response rate (ORR) in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL) 2022-01-13 08:05
Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference 2022-01-13 04:00
Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 2022-01-13 00:00
I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors 2022-01-12 21:00
Gracell Biotechnologies Unveils Innovation Center in U.S. 2022-01-12 21:00
Evolved by Nature Announces IDE Approval from the FDA to Initiate a Pivotal Clinical Trial for its first Activated Silk™ Dermal Filler 2022-01-12 21:00
South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine 2022-01-12 20:43
Bionomics Limited participated in the H.C Wainwright BioConnect Conference 2022-01-12 19:00
Singapore biotech firm JN Medsys develops a PCR test kit that specifically detects for the Omicron variant with high accuracy 2022-01-12 18:18
BGI Genomics, Chinese gene test company, showcases high-throughput COVID testing air lab at Dubai World Expo 2022-01-12 17:18
Transcenta to Present Two Phase I Clinical Trials of TST001 at Upcoming ASCO GI and IGCC 2022-01-12 15:15
Ascentage Pharma Presented at the 40th Annual J.P. Morgan Healthcare Conference Reporting Steady Transition Towards a Full-Fledged Biopharma 2022-01-12 10:19
ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease 2022-01-12 07:59
Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A 2022-01-12 03:40
19Labs, QT Medical Launch Complete Telehealth Solutions With 12-Lead Resting ECG, Ultrasound, & More 2022-01-12 00:30
PostEra Closes $24M in New Financing to Advance Drug Discovery 2022-01-11 22:00
Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity 2022-01-11 21:30
1 294 295 296 297 298 892